Everolimus and Long-term Clinical Outcomes in Kidney Transplant Recipients

AbstractBackgroundData regarding the long-term efficacy of everolimus-based immunosuppression for kidney transplantation are lacking. Existing randomised controlled trials are limited by short follow-up duration which limits capacity to assess impact on graft and patient survival.MethodsWe linked in